Intas Pharmaceuticals Limited Topotecan Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Topotecan Export Records India — #1 Exporter, 414 Shipments, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Topotecan

India Pharmaceutical Trade Intelligence

$3.8M45 Suppliers51 CountriesHS 30049049

ExportsIndia → POLAND29.8%India → NETHERLANDS15.7%

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: ACCORD HEALTHCARE

Intas Pharmaceuticals Limited — Topotecan Exporter #1 | $3.3M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Topotecan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Topotecan · $3.3M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Topotecan with $3.3M in export value and 414 verified shipments. Intas Pharmaceuticals Limited holds a 87.5% market share in Topotecan exports across 16 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Topotecan Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Topotecan export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Topotecan?

Country	Value	Shipments	Share
POLAND	$1.0M	67	34.9%
NETHERLANDS	$564.1K	74	19.6%
UNITED STATES	$504.6K	19	17.5%
BRAZIL	$302.9K	7

Who Are the Top Buyers of Topotecan from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$486.5K	18
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$410.1K	15
TO THE ORDER	HUNGARY	$254.6K	62
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$225.6K	20
ALLOGA FRANCE	NETHERLANDS	$195.7K	15
ACCORD FARMACUTICA LTDA	BRAZIL	$152.9K	4
BROCACEF NL : HUB	NETHERLANDS	$112.4K	16
ACCORD FARMACUTICA LTDA.	BRAZIL	$100.0K	2
ACCORD HEALTHCARE, SLU	SPAIN	$82.1K	4
ACCORD HEALTHCARE ITALIA SRL	ITALY	$70.6K	8

Intas Pharmaceuticals Limited supplies Topotecan to 48 buyers globally. The largest buyer is ACCORD HEALTHCARE POLSKA SP. Z O.O. (POLAND), followed by EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) and TO THE ORDER (HUNGARY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Topotecan Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,	$236.3K	23
PHARMA DRUGS & MEDI TOPOTECAN FOR INJ 4	$118.9K	4
TOPOTECAN RTU 1MG/ML, 4ML 1V(ACC-US) Eac	$108.0K	4
PHARMA DRUGS AND MEDI TOPOTECAN HCL FORINJ. 4 MG/VIAL AS PER INV	$100.0K	2
PHA.DRU & MEDI, TOPOTECAN INJ1MG/ML,4ML	$85.8K	2
PHARMA DRUG&MED:TOPOTECAN RTU,1MG/ML,4ML	$85.6K	7
PHARMA DRUG&MED:TOPOTECAN INJ1MG/ML,4ML	$62.9K	5
PHARMA DRUGS MEDI TOPOTECAN INJ1MG ML 4ML RTU ACCOR FRANCE AS PER INVOICE	$56.5K	3
PHARMA DRUGS MEDI TOPOTECAN HCL FOR INJ 4 MG VIAL AS PER INVOICE	$52.9K	2
PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,4ML RTU(ACCOR-FRANCE AS PER INVOICE	$52.7K	4

Intas Pharmaceuticals Limited exports 253 distinct Topotecan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, with 23 shipments worth $236.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Topotecan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$3.3M	414	16	$7.9K
2	VENUS REMEDIES LIMITED	$224.6K	30	8	$7.5K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$111.1K	4	1	$27.8K

Intas Pharmaceuticals Limited ranks #1 among 45 Indian Topotecan exporters. Average shipment value of $7.9K compared to the market average of $81.5K. The closest competitors by value are VENUS REMEDIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Topotecan Exports?

Port	Shipments	% Share
AHEMDABAD AIR ACC (INAMD4)	107	19.2%
MUNDRA SEA (INMUN1)	86	15.4%
AHEMDABAD AIR	73	13.1%
MUNDRA SEA	48	8.6%
SAHAR AIR CARGO ACC (INBOM4)	45	8.1%
SAHAR AIR	38	6.8%
DELHI AIR CARGO ACC (INDEL4)	36	6.5%
Ahmedabad Air	23	4.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Topotecan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Topotecan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 415 individual customs records matching Intas Pharmaceuticals Limited exporting Topotecan, covering 253 formulations to 16 countries via 48 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 51+ countries, 113+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Topotecan

Topotecan

Intas Pharmaceuticals Limited — Topotecan Exporter Profile

Intas Pharmaceuticals Limited — Topotecan Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Topotecan?

Who Are the Top Buyers of Topotecan from Intas Pharmaceuticals Limited?

What Is India's Total Topotecan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Topotecan Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Topotecan Exporters?

What Topotecan Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Topotecan to Key Markets

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Topotecan Exporters?

Which Indian Ports Ship Topotecan Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Topotecan Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Topotecan Export Data from Intas Pharmaceuticals Limited

Topotecan Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source